Plant ID: NPO2706
Plant Latin Name: Glochidion Eriocarpum
Taxonomy Genus: Glochidion
Taxonomy Family: Phyllanthaceae
NCBI TaxonomyDB:
648869
Plant-of-the-World-Online:
n.a.
Ingredient ID: NPC97557
Ingredient ID: NPC9186
Ingredient ID: NPC57469
Ingredient ID: NPC327298
Ingredient ID: NPC321344
Ingredient ID: NPC293803
Ingredient ID: NPC280278
Ingredient ID: NPC265800
Ingredient ID: NPC233209
Ingredient ID: NPC233059
Ingredient ID: NPC230934
Ingredient ID: NPC186385
Ingredient ID: NPC17190
Ingredient ID: NPC16577
Ingredient ID: NPC116119
Ingredient ID: NPC115402
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Therapeutic Target | Small molecule receptor (family A GPCR) | CNR2 | Cannabinoid CB2 receptor | P34972 | CHEMBL253 |
Therapeutic Target | Small molecule receptor (family A GPCR) | CNR1 | Cannabinoid CB1 receptor | P21554 | CHEMBL218 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 60 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT05276232 | Detection of Cannabis Impairment With ISBRG's SpotLight-THC | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT00377468 | Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study) | complex regional pain syndrome | Cannabinol (NPC16577) | NP level |
NCT05320367 | A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT01040910 | Cannabis for Inflammatory Bowel Disease | Crohn's disease;ulcerative colitis | Cannabinol (NPC16577) | NP level |
NCT02177513 | Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT05288010 | CANPAIN Feasibility Study Pragmatic Real World Trial Investigating CBMP in Chronic Pain Patients | Chronic pain | Cannabinol (NPC16577) | NP level |
NCT00260741 | Cannabis for Spasticity in Multiple Sclerosis | multiple sclerosis | Cannabinol (NPC16577) | NP level |
NCT02165176 | Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT05407285 | A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT03274440 | Effects of Marijuana on Symptoms of OCD | obsessive-compulsive disorder | Cannabinol (NPC16577) | NP level |
NCT02710097 | Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT04124432 | Behavioral Pharmacology of Cannabis and Nicotine | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT02892591 | Cannabis Versus Oxycodone for Pain Relief | Back pain;Neck pain | Cannabinol (NPC16577) | NP level |
NCT03766971 | Influence of Tobacco Use on Cannabis Use | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT05219370 | Treatment With Cannabis Oil Containing CBD, THC, CBDV or CBG vs. Placebo of Persons With ADHD | attention deficit hyperactivity disorder | Cannabinol (NPC16577) | NP level |
NCT05092191 | Cannabis as a Complementary Treatment in Multiple Sclerosis | multiple sclerosis | Cannabinol (NPC16577) | NP level |
NCT04992962 | Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the Knee | osteoarthritis, knee | Cannabinol (NPC16577) | NP level |
NCT04693884 | Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT00254761 | Effects of Smoked Marijuana on Neuropathic Pain | neuropathic pain | Cannabinol (NPC16577) | NP level |
NCT01771731 | Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease | sickle cell anemia | Cannabinol (NPC16577) | NP level |
NCT05212493 | The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder | autism spectrum disorder | Cannabinol (NPC16577) | NP level |
NCT02759185 | Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSD | post-traumatic stress disorder | Cannabinol (NPC16577) | NP level |
NCT00628706 | Investigating the Acute Effects of THC on Functional Brain Systems | memory impairment | Cannabinol (NPC16577) | NP level |
NCT01555983 | Vaporized Cannabis and Spinal Cord Injury Pain | Spinal cord injury | Cannabinol (NPC16577) | NP level |
NCT03246113 | Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma | glioblastoma multiforme | Cannabinol (NPC16577) | NP level |
NCT05114460 | Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal | opioid dependence | Cannabinol (NPC16577) | NP level |
NCT04269993 | Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis | psoriatic arthritis | Cannabinol (NPC16577) | NP level |
NCT00373503 | Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT03581058 | Neural Correlates of Driving and Cannabis | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT00308555 | Opioid and Cannabinoid Pharmacokinetic Interactions | pain | Cannabinol (NPC16577) | NP level |
NCT00743366 | Effect of Quetiapine on Marijuana Withdrawal and Relapse | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT01562483 | The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain | Abdominal pain;Chronic pain | Cannabinol (NPC16577) | NP level |
NCT02324777 | Cannabinoid Profile Investigation of Vapourized Cannabis in Patients With Osteoarthritis of the Knee | osteoarthritis, knee | Cannabinol (NPC16577) | NP level |
NCT03944447 | Outcomes Mandate National Integration With Cannabis as Medicine | AIDS;amyotrophic lateral sclerosis;anxiety;autism;bipolar disorder;brain injury;cancer;COVID-19;Crohn's disease;depressive disorder;fibromyalgia;glaucoma;hepatitis C virus infection;insomnia;opioid use disorder;Parkinson disease;post-traumatic stress disorder;Seizure;severe acute respiratory syndrome;sickle cell anemia;Tourette syndrome;ulcerative colitis;Chronic pain;epilepsy;multiple sclerosis | Cannabinol (NPC16577) | NP level |
NCT05488509 | Acute Effects of Cannabis on Everyday Life Memory | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT05432206 | MEDical CANnabis for Improving Symptoms During Severe DEMentia Disorders in Long-term Care Facility in Geneva | Dementia | Cannabinol (NPC16577) | NP level |
NCT04601207 | A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT00781001 | Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy | diabetic neuropathy | Cannabinol (NPC16577) | NP level |
NCT03639064 | Cannabis Oil for Pain in Parkinson's Disease | Parkinson disease | Cannabinol (NPC16577) | NP level |
NCT05344170 | Cannabinol Use in Patients With Insomnia Disorder | insomnia | Cannabinol (NPC16577) | NP level |
NCT03676166 | Pharmacokinetic and Pharmacodynamic Effects of Smoked and Vaporized Cannabis | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT04982965 | Brain Mechanisms Supporting Cannabis-induced Pain Relief | Chronic pain | Cannabinol (NPC16577) | NP level |
NCT03253926 | Effect of Lorcaserin on Cannabis Withdrawal and Self-administration | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT00552604 | MUltiple Sclerosis and Extract of Cannabis (MUSEC) Study | Spasticity | Cannabinol (NPC16577) | NP level |
NCT01969474 | Effectiveness of Cannabis in the Treatment of Tinnitus Patients | Tinnitus | Cannabinol (NPC16577) | NP level |
NCT02955329 | Vaping THC From Electronic Cigarettes | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT05413187 | A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder | autism | Cannabinol (NPC16577) | NP level |
NCT00255580 | Medicinal Cannabis for Painful HIV Neuropathy | neuropathic pain | Cannabinol (NPC16577) | NP level |
NCT03664141 | Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study) | marasmus | Cannabinol (NPC16577) | NP level |
NCT01502046 | Neuroprotection by Cannabinoids in Huntington's Disease | Huntington disease | Cannabinol (NPC16577) | NP level |
NCT03546790 | Laboratory Smoking of Marijuana "Blunts" | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT03204305 | Brain Imaging of Cannabinoid Receptors | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT03808935 | Cannabis Extract in Refractory Epilepsy Study | epilepsy | Cannabinol (NPC16577) | NP level |
NCT00373295 | Effect of Baclofen on Marijuana Withdrawal and Relapse | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT03929835 | Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa | hidradenitis suppurativa | Cannabinol (NPC16577) | NP level |
NCT04841993 | Pharmacokinetics and Pharmacological Effects of a Standardized Cannabis Preparation | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT00248378 | Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis | multiple sclerosis | Cannabinol (NPC16577) | NP level |
NCT05283161 | CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) | fibromyalgia | Cannabinol (NPC16577) | NP level |
NCT00682929 | Cannabis for Spasticity in Multiple Sclerosis | multiple sclerosis | Cannabinol (NPC16577) | NP level |
NCT03247244 | Safety and Efficacy of Cannabis in Tourette Syndrome | Tourette syndrome | Cannabinol (NPC16577) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
NCT05092191,NCT00248378,NCT00260741,NCT00682929,NCT03944447
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CNR1,CNR2
NCT03944447,NCT05344170 |
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
NCT03944447,NCT04982965,NCT01562483,NCT05288010
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
CNR1,CNR2
NCT00308555 |
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
CNR2
NCT03944447,NCT01040910 |
Epilepsy/seizureDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A61-8A6Z |
NCT03808935,NCT03944447,NCT03944447
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
NCT05413187,NCT03944447,NCT05212493
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
CYP1A1,CNR2,CNR1
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CNR1,CYP1A1,CYP1A2
|
Cannabis use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C41 |
CNR1
NCT02955329,NCT05488509,NCT00743366,NCT03204305,NCT04841993,NCT05320367,NCT03581058,NCT05407285,NCT02165176,NCT04601207,NCT04693884,NCT03253926,NCT04124432,NCT00373295,NCT02177513,NCT03676166,NCT03766971,NCT03546790,NCT05276232,NCT00373503,NCT02710097 |
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
CNR2,CNR1
|
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
CNR2
NCT05219370 |
Opioid use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C43 |
NCT05114460,NCT03944447
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
NCT01040910,NCT03944447
|
Chronic widespread painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.01 |
NCT03944447,NCT05283161
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT03944447,NCT01771731
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
NCT03639064,NCT03944447
|
Osteoarthritis of kneeDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA01 |
NCT02324777,NCT04992962
|
Post-traumatic stress disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B40 |
NCT02759185,NCT03944447
|
Neuropathic painDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43.0 |
NCT00254761,NCT00255580
|
Tourette syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A05.00 |
NCT03247244,NCT03944447
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
CNR2,CNR1
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
CNR1,CNR1
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
CNR2,CYP1B1
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
CNR2,CNR1
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
CYP1B1,CNR2
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
CNR2,CNR1
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
CNR1
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
CNR1
|
Anorexia nervosaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B80 |
CNR1
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
CNR2
|
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
CNR1
|
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
CNR1
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
CNR1
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
CNR1
|
General pain disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43 |
CNR2
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
CNR1
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
CNR1
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
CNR1
|
Abdominal pelvic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD81 |
NCT01562483
|
Age-associated cognitive declineDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.0 |
NCT00628706
|
Cervical spine painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.0 |
NCT02892591
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT03944447
|
Cramp or spasmDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB47.3 |
NCT00552604
|
Obsessive-compulsive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B20 |
NCT03274440
|
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
NCT03944447
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
NCT03944447
|
Injury of spinal cord, level unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51.2 |
NCT01555983
|
Complex regional pain syndromeDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.04 |
NCT00377468
|
Amyotrophic lateral sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60.0 |
NCT03944447
|
Underweight in adultsDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B54 |
NCT03664141
|
Psoriatic arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA21 |
NCT04269993
|
Huntington diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01.10 |
NCT01502046
|
TinnitusDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MC41 |
NCT01969474
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT03944447
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
NCT05432206
|
Diabetic polyneuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C03.0 |
NCT00781001
|
Depressive disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A7Z |
NCT03944447
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT03944447
|
Hidradenitis suppurativaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED92 |
NCT03929835
|
Intracranial injury, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07.Z |
NCT03944447
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT03944447
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT03246113
|
Spinal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84 |
NCT02892591
|
Congenital human immunodeficiency virus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.6 |
NCT03944447
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
NCT03944447
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
CYP1A1
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
CYP1A2
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
CNR1
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
CNR1
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
CNR2
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
CYP1A1
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
CYP1A1
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
CNR1
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
CYP1A2
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
CYP1A1
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
CYP1A1
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
CYP1B1
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
CNR1
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
CYP1A1
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
CNR2
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
CYP1B1
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
CYP1B1
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
CNR2
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
CYP1B1
|